20,000 Patients Treated with BONESUPPORT’s CERAMENT

BONESUPPORT announced the milestone of >20,000 patients treated worldwide with CERAMENT™ injectable drug-eluting bone substitute products.

Company leadership attributes strong adoption to the efforts of its U.S. distribution partner, Zimmer Biomet, and strong surgeon demand in the EU for CERAMENT™|G (gentamicin) and CERAMENT™ V...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us